IL83017A0 - Sustained release pharmaceutical compositions in oral dosage form - Google Patents
Sustained release pharmaceutical compositions in oral dosage formInfo
- Publication number
- IL83017A0 IL83017A0 IL83017A IL8301787A IL83017A0 IL 83017 A0 IL83017 A0 IL 83017A0 IL 83017 A IL83017 A IL 83017A IL 8301787 A IL8301787 A IL 8301787A IL 83017 A0 IL83017 A0 IL 83017A0
- Authority
- IL
- Israel
- Prior art keywords
- oral dosage
- pharmaceutical compositions
- dosage form
- sustained release
- release pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868616669A GB8616669D0 (en) | 1986-07-09 | 1986-07-09 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
IL83017A0 true IL83017A0 (en) | 1987-12-20 |
Family
ID=10600761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL83017A IL83017A0 (en) | 1986-07-09 | 1987-06-29 | Sustained release pharmaceutical compositions in oral dosage form |
Country Status (17)
Country | Link |
---|---|
US (1) | US4919938A (ja) |
EP (1) | EP0253541B1 (ja) |
JP (1) | JP2528130B2 (ja) |
KR (1) | KR880001288A (ja) |
AT (1) | ATE67408T1 (ja) |
AU (1) | AU598280B2 (ja) |
CA (1) | CA1303502C (ja) |
DE (1) | DE3773070D1 (ja) |
DK (1) | DK352387A (ja) |
ES (1) | ES2038181T3 (ja) |
GB (1) | GB8616669D0 (ja) |
GR (1) | GR3002755T3 (ja) |
IE (1) | IE59786B1 (ja) |
IL (1) | IL83017A0 (ja) |
NZ (1) | NZ220875A (ja) |
PT (1) | PT85213B (ja) |
ZA (1) | ZA874960B (ja) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4786509A (en) * | 1987-05-18 | 1988-11-22 | Schering Corporation | Dry sustained release theophylline oral formulation |
EP0325086A3 (en) * | 1987-11-23 | 1990-10-31 | Jago Research Ag | Novel methods for obtaining therapeutic systems with controlled release of the drug |
DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
FR2640876B1 (ja) * | 1988-12-28 | 1993-09-24 | Jouveinal Sa | |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
US5030452A (en) * | 1989-01-12 | 1991-07-09 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
US5108756A (en) * | 1989-01-12 | 1992-04-28 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
US4931286A (en) * | 1989-04-19 | 1990-06-05 | Aqualon Company | High gloss cellulose tablet coating |
US5175003A (en) * | 1990-04-06 | 1992-12-29 | Biosytes Usa, Inc. | Dual mechanism controlled release system for drug dosage forms |
US5576306A (en) * | 1991-03-01 | 1996-11-19 | Dow Chemical Company | Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
US5721221A (en) * | 1991-03-08 | 1998-02-24 | Regents Of The University Of Minnesota | Lowering blood cholesterol levels using water soluble cellulose ethers |
KR100205276B1 (ko) * | 1991-10-04 | 1999-07-01 | 가마쿠라 아키오 | 서방성 정제 |
WO1994015643A1 (en) * | 1992-12-30 | 1994-07-21 | Fmc Corporation | Readily available konjac glucomannan sustained release excipient |
WO1997004752A1 (en) * | 1995-07-26 | 1997-02-13 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions of conjugated estrogens and methods for their use |
US5948437A (en) * | 1996-05-23 | 1999-09-07 | Zeneca Limited | Pharmaceutical compositions using thiazepine |
WO1998027845A1 (en) * | 1996-12-20 | 1998-07-02 | Reckitt & Colman France | Improvements in or relating to packaging |
US6656502B1 (en) * | 1997-03-14 | 2003-12-02 | Toray Industries, Inc. | Sustained-release prostaglandin I derivative preparation |
US5948440A (en) * | 1997-12-17 | 1999-09-07 | Ranbaxy Laboratories Limited | Modified release matrix formulation of cefaclor and cephalexin |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
US20020028240A1 (en) * | 2000-04-17 | 2002-03-07 | Toyohiro Sawada | Timed-release compression-coated solid composition for oral administration |
WO2001080824A2 (en) * | 2000-04-19 | 2001-11-01 | Eurand America, Inc. | Dual mechanism timed release dosage forms for low dose drugs |
US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
US6881420B2 (en) | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
US20030175349A1 (en) * | 2001-01-30 | 2003-09-18 | Council Of Scientific And Industrial Research | Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient |
DE10149674A1 (de) | 2001-10-09 | 2003-04-24 | Apogepha Arzneimittel Gmbh | Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung |
ES2282492T3 (es) | 2001-11-30 | 2007-10-16 | Pfizer Products Inc. | Composiciones farmaceuticas de liberacion controlada orales de 5,8,14-triazatetraciclo (10.3.1.0(2,11).0(4,9)-hexadeca-2(11)3,5,7,9-pentaeno. |
WO2003055525A1 (fr) * | 2001-12-25 | 2003-07-10 | Takeda Chemical Industries, Ltd. | Preparations contenant un acide |
EP1485078B1 (en) * | 2002-03-15 | 2012-09-26 | Cypress Bioscience, Inc. | Milnacipran for the treatment of irritable bowel syndrome |
TW200306866A (en) * | 2002-05-07 | 2003-12-01 | Akzo Nobel Nv | A method to improve surface properties of pharmaceutical tablets |
US20040132826A1 (en) * | 2002-10-25 | 2004-07-08 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
US20060003004A1 (en) * | 2002-10-25 | 2006-01-05 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
BR0315731A (pt) * | 2002-10-30 | 2005-09-06 | Pharmacia Corp | Comprimidos orais de liberação prolongada e métodos para fabricar e usar os mesmos |
AU2004207578B2 (en) * | 2003-01-28 | 2007-06-28 | Collegium Pharmaceutical, Inc. | Multiparticulate compositions of milnacipran for oral administration |
US7387793B2 (en) | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
US20050215561A1 (en) * | 2004-03-19 | 2005-09-29 | Krishnendu Ghosh | Pharmaceutical dosage forms and compositions |
EP1811975A2 (en) * | 2004-10-19 | 2007-08-01 | The State of Oregon Acting by and | Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid |
CN100548309C (zh) * | 2004-11-24 | 2009-10-14 | 东北制药总厂 | 司他夫定缓释片剂 |
EP2412366A4 (en) * | 2009-03-25 | 2013-08-07 | Lintec Corp | SOLID PREPARATION |
CA2882713A1 (en) * | 2012-08-22 | 2014-02-27 | Xenoport, Inc. | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
JPS5659707A (en) * | 1979-10-19 | 1981-05-23 | Toyo Jozo Co Ltd | Lasting antibiotic pharmaceutical and its preparation |
US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
JPS5770816A (en) * | 1980-10-17 | 1982-05-01 | Ono Pharmaceut Co Ltd | Multilayered film preparation of prostagladin of prolonged action |
US4420480A (en) * | 1981-11-20 | 1983-12-13 | Merck & Co., Inc. | Hexahydronaphth[1,2-b]-1,4-oxazines |
CA1204745A (en) * | 1981-11-20 | 1986-05-20 | Merck Co. | Hexahydronaphth (1,2-b) -1,4 -oxazines |
JPS58134019A (ja) * | 1982-02-05 | 1983-08-10 | Ono Pharmaceut Co Ltd | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
DK151608C (da) * | 1982-08-13 | 1988-06-20 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse |
US4505890A (en) | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
FR2556965B1 (fr) | 1983-12-21 | 1986-08-22 | Rhone Poulenc Sante | Nouvelle forme galenique du ketoprofene a liberation controlee |
HU193979B (en) * | 1984-06-12 | 1987-12-28 | Sandoz Ag | Process for producing naphtoxazine derivatives and pharmaceutical compositions containing them |
US4610870A (en) | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
AU592065B2 (en) * | 1984-10-09 | 1990-01-04 | Dow Chemical Company, The | Sustained release dosage form based on highly plasticized cellulose ether gels |
US4695591A (en) * | 1985-03-29 | 1987-09-22 | Schering Corporation | Controlled release dosage forms comprising hydroxypropylmethylcellulose |
US4693896A (en) * | 1985-10-07 | 1987-09-15 | Fmc Corporation | Ethylcellulose-coated, gastric-disintegrable aspirin tablet |
US4816264A (en) * | 1986-06-06 | 1989-03-28 | Warner-Lambert Company | Sustained release formulations |
IT1213080B (it) * | 1986-06-17 | 1989-12-07 | Recordati Chem Pharm | Sistemi terapeutico per la cessione controllata di farmaci. |
-
1986
- 1986-07-09 GB GB868616669A patent/GB8616669D0/en active Pending
-
1987
- 1987-06-29 IL IL83017A patent/IL83017A0/xx not_active IP Right Cessation
- 1987-06-29 NZ NZ220875A patent/NZ220875A/en unknown
- 1987-06-30 PT PT85213A patent/PT85213B/pt not_active IP Right Cessation
- 1987-07-02 ES ES198787305872T patent/ES2038181T3/es not_active Expired - Lifetime
- 1987-07-02 AT AT87305872T patent/ATE67408T1/de not_active IP Right Cessation
- 1987-07-02 EP EP87305872A patent/EP0253541B1/en not_active Expired - Lifetime
- 1987-07-02 DE DE8787305872T patent/DE3773070D1/de not_active Expired - Lifetime
- 1987-07-07 CA CA000541438A patent/CA1303502C/en not_active Expired - Lifetime
- 1987-07-08 AU AU75340/87A patent/AU598280B2/en not_active Ceased
- 1987-07-08 IE IE183087A patent/IE59786B1/en not_active IP Right Cessation
- 1987-07-08 DK DK352387A patent/DK352387A/da not_active Application Discontinuation
- 1987-07-08 KR KR1019870007296A patent/KR880001288A/ko not_active Application Discontinuation
- 1987-07-08 ZA ZA874960A patent/ZA874960B/xx unknown
- 1987-07-09 JP JP62169920A patent/JP2528130B2/ja not_active Expired - Lifetime
-
1989
- 1989-10-04 US US07/418,821 patent/US4919938A/en not_active Expired - Fee Related
-
1991
- 1991-09-19 GR GR91401366T patent/GR3002755T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK352387A (da) | 1988-01-10 |
AU7534087A (en) | 1988-01-14 |
PT85213B (pt) | 1990-03-30 |
GR3002755T3 (en) | 1993-01-25 |
AU598280B2 (en) | 1990-06-21 |
JP2528130B2 (ja) | 1996-08-28 |
ES2038181T3 (es) | 1993-07-16 |
JPS6323814A (ja) | 1988-02-01 |
IE59786B1 (en) | 1994-04-06 |
DE3773070D1 (de) | 1991-10-24 |
EP0253541B1 (en) | 1991-09-18 |
NZ220875A (en) | 1990-11-27 |
ATE67408T1 (de) | 1991-10-15 |
PT85213A (en) | 1987-07-01 |
EP0253541A3 (en) | 1988-04-27 |
IE871830L (en) | 1988-01-09 |
US4919938A (en) | 1990-04-24 |
KR880001288A (ko) | 1988-04-22 |
DK352387D0 (da) | 1987-07-08 |
EP0253541A2 (en) | 1988-01-20 |
CA1303502C (en) | 1992-06-16 |
ZA874960B (en) | 1988-08-31 |
GB8616669D0 (en) | 1986-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0253541A3 (en) | Sustained release pharmaceutical compositions in oral dosage form | |
AT400295B (de) | Orale feste pharmazeutische dosierungsform mit programmierter wirkstofffreisetzung und verfahren zu ihrer herstellung | |
DE3650657D1 (de) | Pharmazeutische Formulierung mit gesteuerter Freigabe | |
DE69212882T2 (de) | Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung | |
DE3773468D1 (de) | Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung. | |
AU6764390A (en) | Pharmaceutical granules and drug dosage units made therefrom | |
ZA952418B (en) | Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration | |
ATE87201T1 (de) | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung. | |
ATE84213T1 (de) | Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung. | |
SE8803822D0 (sv) | Novel dosage form | |
DE3856555D1 (de) | Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption | |
DK166259C (da) | Oral tablet til ph-uafhaengig frigivelse | |
JPS56139468A (en) | 10-substituted-5-cyanmethylene-10,11-dihydro- dibenzo(a,d)cycloheptene, manufacture and medicine containing same | |
AU536527B2 (en) | 10-substituted 5-cyanomethylene-di-benzo(a,d)-cyclo-heptenes | |
DE3772965D1 (de) | Imidazol-derivate mit therapeutischer aktivitaet, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE44734T1 (de) | 4-phenylpropylindolderivate und ihre salze, verfahren zur herstellung, deren anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen. | |
ATA26286A (de) | Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstoffreisetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |